The new medication is personalized for each patient's tumor, mobilizing the immune system to attack cancer cells with few ...

A newly discovered bat coronavirus uses the same cell-surface protein to gain entry into human cells as the SARS-CoV-2 virus that causes Covid-19, raising the possibility that it could someday spread ...

Tasmanians are expected to be able to access a Moderna Covid vaccine manufactured in Australia later this year.

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research.

Persistent levels of spike protein from COVID-19 vaccines could be associated with a range of chronic symptoms like excessive ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna ...

The S&P 500 plunged by 1.7% on Friday, Feb. 21, as weak economic data and earnings forecasts sent the benchmark index lower for the second straight session.

CoV-2, has been discovered in China and is “strikingly similar to the pandemic virus” and feared to be powerful ...

While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...